Category: Health & Medicines > Medicines > Erythropoietin
Country/Region: China State/Province: Shandong
Main Products: Recombinant Human Erythropoietin Injection
Business Type: Supplier, Retailer
Year Established: 2002
Employees: 51 - 100 People
Plant Area: 30,000-50,000 square meters
Main Markets: South America 10% Africa 8% Eastern Asia 8% Domestic Market 10% North America 10% Eastern Europe 9% Southern Europe 12% Mid East 12% Northern Europe 12% Oceania 9%
Trade Capacity: FOB, EXW, DES
Contract Manufacturing: OEM Service Offered Design Service Offered
Nearest Port: Jinan
Annual Revenue: US$2.5 Million - US$5 Million
Total Revenue: confidential
Export Revenue: US$1 Million - US$2.5 Million
Annual Output: Above US$100 Million
Registered Capital: US$10 Million - US$50 Million
Export Percentage: 71% - 80%
Payment Modes: USD, AUD, CHF
Lead Time: 5 days
Import/Export Mode: Have Own Export License